OTC Markets OTCPK - Delayed Quote USD

Life Stem Genetics Inc. (LIFS)

0.0001
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Gloria Simov CEO, President & Director 5k -- 1986
Ms. Heather Sharp Chief Financial Officer, Principal Accounting Officer, Vice President, Secretary and Director -- -- 1972
Dr. Vino Padayachee Chairman & Business Development Director -- -- 1960

Life Stem Genetics Inc.

3300 Parker Lane
East Stroudsburg, PA 18301
United States
Industry: 
Shell Companies

Description

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania.

Corporate Governance

Life Stem Genetics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 20, 2023 at 12:00 AM UTC

15-15D: Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act